Global General & Plastic Surgery Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
European Radiofrequency Ablation The European Radiofrequency Ablation Market was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in European radiofrequency ablation therapy sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.). |
Upcoming |
|
|
Americas Ultrasound Ablation The American Ultrasound Ablation Market was pegged at $644 million in 2013 and expected to be $1155 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming |
|
|
Asia-Pacific Ultrasound Ablation The Asia-Pacific Ultrasound Ablation Market was pegged at $259 million in 2013 and expected to be $535 million by 2018. The key players in Asia-Pacific Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming |
|
|
European Ultrasound Ablation The European Ultrasound Ablation Market was pegged at $286 million in 2013 and expected to be $500 million by 2018. The key players in European Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming |
|
|
Americas Thermal Ablation The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others |
Upcoming |
|
|
Asia-Pacific Thermal Ablation The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
European Thermal Ablation The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Americas Electrical Ablators The electrical ablation market of the Americas, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $387 million in 2013 and is expected to reach $480 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Asia-Pacific Electrical Ablators The Asia-Pacific electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $159 million in 2013 and is expected to reach $236 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
European Electrical Ablators The European electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $189 million in 2013 and is expected to reach $228 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
European Brachytherapy The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Asia-Pacific Brachytherapy The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
Americas Brachytherapy The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
|
|
North America Intrauterine Contraceptive Devices The growth of the intrauterine contraceptive devices market is driven by various factors, such as the rising rate of unplanned pregnancies, effective contraception and minimum side effects of IUCD, implementation of the Affordable Care Act (ACA), higher number of initiatives undertaken by private firms directed towards reducing the expenses related to abortion, and the various technological advancements. |
Feb 2015 |
|
|
Intrauterine Contraceptive Devices Intrauterine Contraceptive Devices and Facial Aesthetics Devices, |
Apr 2015 |
|
|
Europe Stationary cycles The major drivers of the European stationary cycle market include the increasing number of diabetes and cardiac patients; increasing personal disposable incomes; and government initiatives to increase health and fitness awareness. For instance, in Italy, the government issued a plan for the prevention of obesity. The plan includes actions such as breastfeeding promotion, eating habits improvement, enhancing physical activity at schools and workplaces, and promotion and facilitation of physical activity in the urban areas. |
Feb 2015 |
|
|
North American Stationary cycles Stationary cycles - North America constitute 0.5% of Global Stationary cycles market and are poised to grow its market share to 0.4% by the end of year 2019. It is segmented on basis of . What makes our report unique? You... |
Feb 2015 |
|
|
Asian Stationary cycles Stationary cycles - Asia constitute 0.0% of Global Stationary cycles market and are poised to grow its market share to 0.0% by the end of year 2019. It is segmented on basis of . What makes our report unique? You can... |
Apr 2015 |
|
|
Hernia Mesh Peers of Hernia Mesh are Weight Loss & Obesity Management, Ablation Devices, Facial Aesthetics Devices and Intrauterine Contraceptive Devices comprising respectively of the Global General Surgery Devices market. It is segmented on basis of . ... |
Upcoming |
|
|
North America Hernia Mesh The North America hernia mesh market is expected to register a CAGR of 1.8% between 2016 and 2021. The Synthetic mesh segment and biological mesh segment both accounted for the largest share; i.e. 50% of the overall hernia mesh market in 2015. Synthetic mesh segment is expected to grow at a CAGR of 0.4% for the forecast period from 2016-2021. |
Upcoming |
General & Plastic Surgery
